These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3203572)

  • 21. Mastery and self-esteem mediate the association between visual acuity and mental health: a population-based longitudinal cohort study.
    Maaswinkel IM; van der Aa HPA; van Rens GHMB; Beekman ATF; Twisk JWR; van Nispen RMA
    BMC Psychiatry; 2020 Sep; 20(1):461. PubMed ID: 32972387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial impact of visual impairment and coping strategies in female ex-Service personnel.
    Stevelink SA; Fear NT
    J R Army Med Corps; 2016 Apr; 162(2):129-33. PubMed ID: 26732099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
    Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    ; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of low vision rehabilitation in diabetic eye disease: a randomised controlled trial protocol.
    Dunbar HM; Crossland MD; Bunce C; Egan C; Rubin GS
    Ophthalmic Physiol Opt; 2012 Jul; 32(4):282-93. PubMed ID: 22620493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early photocoagulation in patients with either type I or type II diabetes.
    Ferris F
    Trans Am Ophthalmol Soc; 1996; 94():505-37. PubMed ID: 8981711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.
    Smith TS; Szetu J; Bourne RR
    Br J Ophthalmol; 2007 Apr; 91(4):415-9. PubMed ID: 17077115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological aspects and depression in patients with retinitis pigmentosa.
    Moschos M; Chatzirallis A; Chatziralli I
    Eur J Ophthalmol; 2015; 25(5):459-62. PubMed ID: 25743781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Nakazawa T; Tamai M
    Am J Ophthalmol; 2005 Jul; 140(1):8-15. PubMed ID: 15939392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correctable visual impairment among people with diabetes in Hong Kong.
    Fung MM; Yap MKh; Cheng KK
    Clin Exp Optom; 2010 Nov; 93(6):453-7. PubMed ID: 21182660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual impairment in diabetes.
    Klein R; Klein BE; Moss SE
    Ophthalmology; 1984 Jan; 91(1):1-9. PubMed ID: 6709312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of visual impairment due to cataract, diabetic retinopathy and trachoma in indigenous Australians within central Australia: the Central Australian Ocular Health Study.
    Landers J; Henderson T; Craig JE
    Clin Exp Ophthalmol; 2013; 41(1):50-5. PubMed ID: 22594763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normative contrast sensitivity values for the back-lit Melbourne Edge Test and the effect of visual impairment.
    Eperjesi F; Wolffsohn J; Bowden J; Napper G; Rubinstein M
    Ophthalmic Physiol Opt; 2004 Nov; 24(6):600-6. PubMed ID: 15491489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic retinopathy and health-related quality of life.
    Davidov E; Breitscheidel L; Clouth J; Reips M; Happich M
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):267-72. PubMed ID: 18925408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of disability related to vision performance-based measure in diabetic retinopathy.
    Warrian KJ; Lorenzana LL; Lankaranian D; Dugar J; Wizov SS; Spaeth GL
    Am J Ophthalmol; 2010 May; 149(5):852-60.e1. PubMed ID: 20399929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinopathy and visual impairment in diabetes, impaired glucose tolerance and normal glucose tolerance: the Nord-Trøndelag Health Study (the HUNT study).
    Sundling V; Platou CG; Jansson RW; Bertelsen G; Wøllo E; Gulbrandsen P
    Acta Ophthalmol; 2012 May; 90(3):237-43. PubMed ID: 20809910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment.
    Laatikainen L; Ojamo M; Rudanko SL; Summanen P; Keinänen-Kiukaanniemi S; Tuomilehto J; Herrala S; Uusitalo H
    Acta Ophthalmol; 2016 May; 94(3):226-31. PubMed ID: 26928978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of visual impairments in self-esteem and locus of control.
    Papadopoulos K; Montgomery AJ; Chronopoulou E
    Res Dev Disabil; 2013 Dec; 34(12):4565-70. PubMed ID: 24176255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.